X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1820) 1820
renal transplant (1782) 1782
science & technology (1757) 1757
life sciences & biomedicine (1754) 1754
male (1280) 1280
female (1126) 1126
transplantation (1111) 1111
adult (974) 974
middle aged (963) 963
kidney transplantation (951) 951
kidneys (687) 687
kidney transplantation - adverse effects (555) 555
urology & nephrology (457) 457
surgery (417) 417
aged (407) 407
risk factors (374) 374
adolescent (341) 341
renal transplant recipients (336) 336
organ transplant recipients (334) 334
retrospective studies (309) 309
treatment outcome (299) 299
immunosuppressive agents - therapeutic use (298) 298
transplants & implants (258) 258
child (233) 233
immunosuppression (233) 233
immunology (232) 232
health aspects (229) 229
medicine & public health (218) 218
time factors (201) 201
immunosuppressive agents - adverse effects (199) 199
kidney failure, chronic - surgery (197) 197
renal transplant recipient (197) 197
kidney transplantation - immunology (183) 183
pediatrics (183) 183
young adult (181) 181
graft survival (177) 177
analysis (168) 168
pharmacology & pharmacy (168) 168
follow-up studies (164) 164
infectious diseases (156) 156
tacrolimus (150) 150
graft rejection - prevention & control (144) 144
health risk assessment (132) 132
kidney diseases (130) 130
kidney transplantation - methods (127) 127
care and treatment (125) 125
prospective studies (125) 125
biopsy (121) 121
graft rejection (120) 120
nephrology (118) 118
immunosuppressive agents - administration & dosage (109) 109
child, preschool (108) 108
internal medicine (108) 108
patients (100) 100
research (99) 99
case report (98) 98
graft rejection - immunology (97) 97
immunocompromised host (97) 97
prognosis (96) 96
transplantation, homologous (96) 96
mortality (93) 93
cyclosporine - therapeutic use (91) 91
incidence (90) 90
immunotherapy (86) 86
kidney transplantation - physiology (86) 86
prevalence (86) 86
cyclosporine (83) 83
cytomegalovirus (83) 83
transplant recipients (83) 83
hypertension (81) 81
glomerular filtration rate (80) 80
kidney transplantation - mortality (80) 80
immunosuppressive agents - pharmacokinetics (79) 79
postoperative complications (78) 78
drug therapy, combination (76) 76
general & internal medicine (76) 76
tissue donors (76) 76
pharmacology/toxicology (75) 75
creatinine - blood (73) 73
medicine, general & internal (73) 73
kidney failure, chronic - complications (72) 72
medicine (72) 72
pharmacotherapy (72) 72
animals (71) 71
complications and side effects (70) 70
immunosuppressive agents (70) 70
chronic kidney failure (69) 69
diagnosis (69) 69
tacrolimus - therapeutic use (69) 69
infections (68) 68
medical research (68) 68
living donors (66) 66
diseases of the genitourinary system. urology (64) 64
cohort studies (63) 63
cross-sectional studies (63) 63
diabetes (63) 63
kidney failure, chronic - therapy (63) 63
original (63) 63
genotype (62) 62
medicine, experimental (62) 62
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2728) 2728
Spanish (25) 25
French (18) 18
Japanese (18) 18
Korean (15) 15
Portuguese (15) 15
German (7) 7
Chinese (4) 4
Russian (4) 4
Persian (3) 3
Polish (3) 3
Croatian (1) 1
Czech (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
British Journal of Dermatology, ISSN 0007-0963, 03/2006, Volume 154, Issue 3, pp. 472 - 477
Journal Article
Journal Article
Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 07/2018, Volume 84, Issue 7, pp. 1587 - 1597
Aims The aims of the present study were to characterize the pharmacokinetics of voriconazole in renal transplant recipients and to identify factors significantly affecting pharmacokinetic parameters... 
CYP2C19 polymorphism | voriconazole | dosing simulation | renal transplant recipients | population pharmacokinetics | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antifungal Agents - adverse effects | Biological Variation, Population - physiology | Body Weight | Prospective Studies | Humans | Middle Aged | Biological Availability | Male | Transplant Recipients | Intestinal Absorption | Dose-Response Relationship, Drug | Young Adult | Voriconazole - administration & dosage | Time Factors | Invasive Fungal Infections - drug therapy | Antifungal Agents - pharmacokinetics | Adult | Female | Immunosuppressive Agents - administration & dosage | Voriconazole - adverse effects | Administration, Oral | Graft Rejection - prevention & control | Postoperative Period | Cytochrome P-450 CYP2C19 - genetics | Genotype | Voriconazole - pharmacokinetics | Models, Biological | Cytochrome P-450 CYP2C19 - metabolism | Immunosuppressive Agents - adverse effects | Polymorphism, Single Nucleotide | Graft Rejection - immunology | Antifungal Agents - administration & dosage | Invasive Fungal Infections - immunology | Kidney Transplantation - adverse effects | Kidneys | Analysis | Cytochrome P-450 | Mycoses | Organ transplant recipients | Genetic aspects | Transplantation | Index Medicus | Original
Journal Article
Parasitology research (1987), ISSN 1432-1955, 11/2018, Volume 118, Issue 1, pp. 181 - 189
.... This study aimed to determine the prevalence of P. jirovecii and potential risk factors for infection in a group of renal transplant recipients and to characterize the genetic diversity of this fungus in the studied population... 
Medical Microbiology | Biomedicine | Immunology | Prevalence | Microbiology | Renal transplant recipients | Genotyping | Colonization | Pneumocystis jirovecii | Ascomycota | Fungi | Host-parasite relationships | Genotype | Genetic aspects | Health aspects | Statistics | Prevalence studies (Epidemiology) | Index Medicus | Genetics, Evolution, and Phylogeny - Original Paper
Journal Article